Stocks and Investing
by (remove) : Andrew Berens
RSSJSONXMLCSV
Stocks and Investing
by (remove) : Andrew Berens
RSSJSONXMLCSV
Fri, September 27, 2024
Fri, August 16, 2024
Mon, July 22, 2024
Mon, May 6, 2024
Tue, August 15, 2023
Mon, June 5, 2023
Mon, May 8, 2023
Fri, February 24, 2023
Fri, January 20, 2023
Mon, December 12, 2022
Wed, November 23, 2022
Tue, November 22, 2022
Mon, November 14, 2022
Fri, November 11, 2022
Thu, November 10, 2022
Wed, November 2, 2022
Fri, October 21, 2022
Thu, October 13, 2022
Thu, August 18, 2022
Wed, August 10, 2022
Fri, August 5, 2022
Wed, August 3, 2022
Wed, July 27, 2022
Fri, July 1, 2022
Mon, June 13, 2022
Fri, May 27, 2022

Andrew Berens Downgraded (AGIO) to Hold and Decreased Target to $56 on, Sep 27th, 2024


Published on 2024-10-28 14:30:41 - WOPRAI, Andrew Berens
  Print publication without navigation


Andrew Berens of Leerink Partners, Downgraded "Agios Pharmaceuticals, Inc." (AGIO) to Hold and Decreased Target from $60 to $56 on, Sep 27th, 2024.

Andrew has made no other calls on AGIO in the last 4 months.



There are 4 other peers that have a rating on AGIO. Out of the 4 peers that are also analyzing AGIO, 2 agree with Andrew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Tessa Romero of "JP Morgan" Initiated at Hold and Held Target at $46 on, Thursday, June 13th, 2024
  • Salveen Richter of "Goldman Sachs" Maintained at Hold with Increased Target to $53 on, Tuesday, June 4th, 2024


These are the ratings of the 2 analyists that currently disagree with Andrew


  • Eric Schmidt of "Cantor Fitzgerald" Reiterated at Buy on, Friday, September 20th, 2024
  • Gregory Renza of "RBC Capital" Reiterated at Buy and Held Target at $55 on, Thursday, September 19th, 2024
Contributing Sources